111 Capital Makes New $267,000 Investment in Axon Enterprise, Inc $AXON

111 Capital acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 322 shares of the biotechnology company’s stock, valued at approximately $267,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Brighton Jones LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $480,000. Wedmont Private Capital lifted its holdings in shares of Axon Enterprise by 22.8% during the first quarter. Wedmont Private Capital now owns 825 shares of the biotechnology company’s stock valued at $469,000 after purchasing an additional 153 shares during the last quarter. Capital Investment Advisors LLC lifted its holdings in shares of Axon Enterprise by 86.5% during the first quarter. Capital Investment Advisors LLC now owns 1,285 shares of the biotechnology company’s stock valued at $676,000 after purchasing an additional 596 shares during the last quarter. Baldwin Wealth Partners LLC MA boosted its position in shares of Axon Enterprise by 4.9% in the 1st quarter. Baldwin Wealth Partners LLC MA now owns 577 shares of the biotechnology company’s stock worth $303,000 after purchasing an additional 27 shares in the last quarter. Finally, Yousif Capital Management LLC grew its stake in shares of Axon Enterprise by 1.6% in the 1st quarter. Yousif Capital Management LLC now owns 9,961 shares of the biotechnology company’s stock worth $5,239,000 after buying an additional 157 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. JMP Securities reiterated a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a research note on Monday, September 29th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. Needham & Company LLC reiterated a “buy” rating and issued a $870.00 price target on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, Wolfe Research assumed coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Insider Buying and Selling

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares of the company’s stock, valued at $177,892,712.54. The trade was a 6.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 49,932 shares of company stock valued at $37,978,216 in the last ninety days. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 0.8%

Axon Enterprise stock opened at $721.59 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. Axon Enterprise, Inc has a one year low of $416.88 and a one year high of $885.91. The stock has a market capitalization of $56.65 billion, a PE ratio of 178.17, a price-to-earnings-growth ratio of 27.79 and a beta of 1.41. The business’s fifty day moving average is $757.50 and its 200 day moving average is $710.51.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.